BACKGROUND: High mortality in the 2001 US and recent European anthrax outbreaks suggests that better understanding of the effects of the toxins produced by this bacterium is needed to improve treatment. METHODS AND RESULTS: Here, 24-h edema (ETx) and lethal (LeTx) toxin infusions were investigated for 96 hin sedated canines receiving mechanical ventilation. The initial study compared similarly lethal doses of ETx (n=8) or LeTx (n=15) alone. ETx was 24 times less lethal than LeTx, and the median time to death in nonsurvivors (n=6 and n=9, respectively) was shorter with ETx (42 vs 67 h; P=.04). Compared with controls(n=9), both toxins decreased arterial and central venous pressures and systemic vascular resistance and increased heart rate, cardiac index, blood urea nitrogen (BUN) level, creatinine (Cr) concentration, BUN:Cr ratio, and hepatic transaminase levels (P ≤ .05 for toxin effect or time interaction). However, ETx stimulated early diuresis,reduced serum sodium levels, and had more pronounced vasodilatory effects, compared with LeTx, as reflected by greater or earlier central venous pressures, systemic vascular resistance, and changes in the BUN:Cr ratio(P ≤ .01). LeTx progressively decreased the left ventricular ejection fraction (P ≤ .002). In a subsequent study, a lethal dose of LeTx with an equimolar nonlethal ETx dose (n=8) increased mortality, compared with LeTx alone (n=8; P= .05). CONCLUSION: Shock with ETx or LeTx may require differing supportive therapies, whereas toxin antagonists should likely target both toxins.
BACKGROUND: High mortality in the 2001 US and recent European anthrax outbreaks suggests that better understanding of the effects of the toxins produced by this bacterium is needed to improve treatment. METHODS AND RESULTS: Here, 24-h edema (ETx) and lethal (LeTx) toxin infusions were investigated for 96 hin sedated canines receiving mechanical ventilation. The initial study compared similarly lethal doses of ETx (n=8) or LeTx (n=15) alone. ETx was 24 times less lethal than LeTx, and the median time to death in nonsurvivors (n=6 and n=9, respectively) was shorter with ETx (42 vs 67 h; P=.04). Compared with controls(n=9), both toxins decreased arterial and central venous pressures and systemic vascular resistance and increased heart rate, cardiac index, blood ureanitrogen (BUN) level, creatinine (Cr) concentration, BUN:Cr ratio, and hepatic transaminase levels (P ≤ .05 for toxin effect or time interaction). However, ETx stimulated early diuresis,reduced serum sodium levels, and had more pronounced vasodilatory effects, compared with LeTx, as reflected by greater or earlier central venous pressures, systemic vascular resistance, and changes in the BUN:Cr ratio(P ≤ .01). LeTx progressively decreased the left ventricular ejection fraction (P ≤ .002). In a subsequent study, a lethal dose of LeTx with an equimolar nonlethal ETx dose (n=8) increased mortality, compared with LeTx alone (n=8; P= .05). CONCLUSION: Shock with ETx or LeTx may require differing supportive therapies, whereas toxin antagonists should likely target both toxins.
Authors: Michael W Laird; David Zukauskas; Kelly Johnson; Gavin C Sampey; Henrik Olsen; Andy Garcia; Jeffrey D Karwoski; Bridget A Cooksey; Gil H Choi; Janine Askins; Amos Tsai; Jennifer Pierre; William Gwinn Journal: Protein Expr Purif Date: 2004-11 Impact factor: 1.650
Authors: Xizhong Cui; Junwu Su; Yan Li; Joseph Shiloach; Steven Solomon; Jeanne B Kaufman; Haresh Mani; Yvonne Fitz; Jia Weng; Laith Altaweel; Virginia Besch; Peter Q Eichacker Journal: Intensive Care Med Date: 2009-09-15 Impact factor: 17.440
Authors: Daniel J Lips; Orlando F Bueno; Benjamin J Wilkins; Nicole H Purcell; Robert A Kaiser; John N Lorenz; Laure Voisin; Marc K Saba-El-Leil; Sylvain Meloche; Jacques Pouysségur; Gilles Pagès; Leon J De Windt; Pieter A Doevendans; Jeffery D Molkentin Journal: Circulation Date: 2004-04-19 Impact factor: 29.690
Authors: Xizhong Cui; Mahtab Moayeri; Yan Li; Xuemei Li; Michael Haley; Yvonne Fitz; Rosaly Correa-Araujo; Steven M Banks; Stephen H Leppla; Peter Q Eichacker Journal: Am J Physiol Regul Integr Comp Physiol Date: 2004-01-08 Impact factor: 3.619
Authors: J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins Journal: Emerg Infect Dis Date: 2001 Nov-Dec Impact factor: 6.883
Authors: Deliang Chen; Lili Ma; John J Kanalas; Jian Gao; Jennifer Pawlik; Maria Estrella Jimenez; Mary A Walter; Johnny W Peterson; Scott R Gilbertson; Catherine H Schein Journal: Bioorg Med Chem Date: 2011-11-16 Impact factor: 3.641